Hal Drakesmith

ORCID: 0000-0002-8503-6103
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Iron Metabolism and Disorders
  • Hemoglobinopathies and Related Disorders
  • Trace Elements in Health
  • Child Nutrition and Water Access
  • Erythropoietin and Anemia Treatment
  • Erythrocyte Function and Pathophysiology
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • RNA modifications and cancer
  • Malaria Research and Control
  • interferon and immune responses
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Blood disorders and treatments
  • Long-Term Effects of COVID-19
  • Immune Cell Function and Interaction
  • Immune Response and Inflammation
  • Lysosomal Storage Disorders Research
  • Folate and B Vitamins Research
  • Cancer-related molecular mechanisms research
  • Multiple Myeloma Research and Treatments
  • Liver Disease Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Clostridium difficile and Clostridium perfringens research
  • Metabolism, Diabetes, and Cancer

University of Oxford
2016-2025

MRC Weatherall Institute of Molecular Medicine
2016-2025

John Radcliffe Hospital
2015-2025

MRC Human Immunology Unit
2016-2025

Medical Research Council
2005-2024

Oxford BioMedica (United Kingdom)
2015-2021

National Institute for Health Research
2015

NIHR Biomedical Research Centre at The Royal Marsden and the ICR
2015

Center of Molecular Immunology (Cuba)
2009-2011

Institute of Molecular Medicine
2006

David Ahern Zhichao Ai Mark Ainsworth Chris Allan Alice Allcock and 95 more Brian Angus M. Azim Ansari Carolina V. Arancibia-Cárcamo Dominik Aschenbrenner Moustafa Attar J. Kenneth Baillie Eleanor Barnes Rachael Bashford-Rogers Archana Bashyal Sally Beer G. Berridge Amy Beveridge Sagida Bibi Tihana Bicanic Luke Blackwell Paul Bowness Andrew Brent Andrew Brown John Broxholme David Buck Katie L. Burnham Helen M. Byrne Susana Camara Ivan Candido-Ferreira Philip D. Charles Wentao Chen Yi‐Ling Chen Amanda Y. Chong Elizabeth Clutterbuck Mark Coles Christopher P. Conlon Richard J. Cornall Adam P. Cribbs Fabiola Curion Emma E. Davenport Neil Davidson Simon Davis Calliope A. Dendrou Julie Dequaire Lea Dib James Docker Christina Dold Tao Dong Damien J. Downes Hal Drakesmith Susanna Dunachie David A. Duncan Chris Eijsbouts Robert Esnouf Alexis Espinosa Rachel Etherington Benjamin P. Fairfax Rory Fairhead Hai Fang Shayan Fassih Sally Felle Maria Fernandez Mendoza Ricardo Melo Ferreira Román Fischer Thomas Foord Aden Forrow John Frater Anastasia Fries Verónica Sánchez Lucy C. Garner Clementine Geeves Dominique Georgiou Leila Godfrey Tanya Golubchik Maria Gomez Vazquez Angie Green Hong Harper Heather A. Harrington Raphael Heilig Svenja Hester Jennifer Hill Charles Hinds Clare Hird Ling‐Pei Ho Renee S. Hoekzema Benjamin Hollis Jim R. Hughes Paula Hutton Matthew A. Jackson-Wood Ashwin Jainarayanan Anna James-Bott Kathrin Jansen Katie Jeffery Elizabeth Jones Luke Jostins Georgina Kerr David Kim Paul Klenerman Julian C. Knight Vinod Kumar

Treatment of severe COVID-19 is currently limited by clinical heterogeneity and incomplete description specific immune biomarkers. We present here a comprehensive multi-omic blood atlas for patients with varying severity in an integrated comparison influenza sepsis versus healthy volunteers. identify signatures correlates host response. Hallmarks disease involved cells, their inflammatory mediators networks, including progenitor cells myeloid lymphocyte subsets, features the repertoire,...

10.1016/j.cell.2022.01.012 article EN cc-by Cell 2022-01-21

Abstract Persistent symptoms following SARS-CoV-2 infection are increasingly reported, although the drivers of post-acute sequelae (PASC) COVID-19 unclear. Here we assessed 214 individuals infected with SARS-CoV-2, varying disease severity, for one year from symptom onset to determine early correlates PASC. A multivariate signature detected beyond two weeks disease, encompassing unresolving inflammation, anemia, low serum iron, altered iron-homeostasis gene expression and emerging stress...

10.1038/s41590-024-01754-8 article EN cc-by Nature Immunology 2024-03-01

Significance Altered iron levels correlate with disease progression in HIV type-1 (HIV-1) infection, and cellular promotes HIV-1 replication. In chronic hepatitis B virus (HBV) C (HCV) infections, increased liver contribute to disease. The peptide hormone hepcidin controls distribution. We find that increases during the acute phase of early predicts later plasma viral set-point, remains high even chronically infected individuals receiving antiretroviral therapy. Conversely is not induced,...

10.1073/pnas.1402351111 article EN Proceedings of the National Academy of Sciences 2014-08-04

BackgroundHow specific nutrients influence adaptive immunity is of broad interest. Iron deficiency the most common micronutrient worldwide and imparts a significant burden global disease; however, its effects on remain unclear.MethodsWe used hepcidin mimetic several genetic models to examine effect low iron availability T cells in vitro immune responses vaccines viral infection mice. We examined humoral human patients with raised serum caused by mutant TMPRSS6. tested supplementation...

10.1016/j.medj.2020.10.004 article EN cc-by-nc-nd Med 2020-11-20

Background: Iron deficiency may impair adaptive immunity and is common among African infants at time of vaccination. Whether iron impairs vaccine response whether supplementation improves humoral uncertain. Methods: We performed two studies in southern coastal Kenya. In a birth cohort study, we followed to age 18mo assessed anemia or vaccination predicted three-valent oral polio, diphtheria-tetanus-whole cell pertussis-Haemophilus influenzae type b vaccine, ten-valent pneumococcal-conjugate...

10.3389/fimmu.2020.01313 article EN cc-by Frontiers in Immunology 2020-07-13

Background: Antenatal anemia is a risk factor for adverse maternal and fetal outcomes prevalent in sub-Saharan Africa. Less than half of antenatal considered responsive to iron; identifying women need iron may help target interventions. Iron absorption governed by the iron-regulatory hormone hepcidin. Objective: We sought characterize changes hepcidin its associations with indexes stores, erythropoiesis, inflammation at weeks 14, 20, 30 gestation assess hepcidin's diagnostic potential as an...

10.3945/jn.116.245373 article EN cc-by Journal of Nutrition 2017-04-19

Natural killer (NK) cells are important early responders against viral infections. Changes in metabolism crucial to fuel NK cell responses, and altered is linked dysfunction obesity cancer. However, very little known about the metabolic requirements of during acute retroviral infection their importance for antiviral immunity. Here, using Friend retrovirus mouse model, we show that following increase nutrient uptake, including amino acids iron, reprogram machinery by increasing glycolysis...

10.1038/s41467-021-25715-z article EN cc-by Nature Communications 2021-09-10

Low plasma iron (hypoferremia) induced by hepcidin is a conserved inflammatory response that protects against infections but inhibits erythropoiesis. How hypoferremia influences leukocytogenesis unclear. Using proteomic data, we predicted neutrophil production would be profoundly more iron-demanding than generation of other white blood cell types. Accordingly in mice, hepcidin-mediated substantially reduced numbers granulocytes not monocytes, lymphocytes, or dendritic cells. Neutrophil...

10.1126/sciadv.abq5384 article EN cc-by-nc Science Advances 2022-10-05
Coming Soon ...